What's the Next Big Thing in the Recombinant Vaccines Market? GlaxoSmithKline Biologicals, MERCK & CO., INC, Dynavax Technologies Corporation
The year on year revenue growth of recombinant vaccines landscape is projected to reach its peak post 2020, indicates Future Market Insights.
View full press release